Hearing on Food and Drug Administration Activities.

Continuation of hearing to review FDA regulation of oral contraceptives, particularly the new drug Demulen, to examine FDA drug approval process and labeling regulations, and to review research on possible health risks of oral contraceptives containing high dosages of estrogen.

Bibliographic Details

Corporate Author:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (other agent associated with work.)
Format:	eBook
Language:	English
Published:	[Washington : U.S. G.P.O.], 1970.
Subjects:	Contraceptives. Drugs. Estrogen.
Online Access:	Electronic resource (PDF)